23 March 2023 01:01 p.m. All figures in US dollars. The loss announced by Exscientia PLC in the fourth quarter were lower than the Refinitiv mean estimate of losses. The company reported losses of -
* Exscientia PLC reported a quarterly adjusted loss of 38 cents per share for the quarter ended in December. The mean expectation of three analysts for the quarter was for a loss of 32 cents per
March 23 (Reuters) - ECO Animal Health Group PLC : * ECO ANIMAL HEALTH GP - TRADING UPDATE * ECO ANIMAL HEALTH SEES REVENUE AND EARNINGS BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION SLIGHTLY
March 22 (Reuters) - Amryt Pharma PLC * AMRYT PHARMA SHAREHOLDERS APPROVE ACQUISITION OF AMRYT PHARMA BY CHIESI FARMACEUTICI * AMRYT PHARMA PLC - TRANSACTION EXPECTED TO CLOSE IN Q2 2023 Source text
March 22 (Reuters) - Tc Biopharm Ltd: * TC BIOPHARM ANNOUNCES CORPORATE RESTRUCTURING, REDUCTION IN OVERHEAD * COMPANY IS REDUCING ITS WORKFORCE UP TO 30%, WITH MAJORITY OF REDUCTION EXPECTED TO BE
March 22 (Reuters) - Bookrunner: * AZELIS GROUP NV ABO OFFERING PRICE: EUR 23.60 PER SHARE- BOOKRUNNER Source text for Eikon: Further company coverage:
March 22 (Reuters) - Hellenic Dynamics PLC: * HELLENIC DYNAMICS PLC - MEMORANDUM OF UNDERSTANDING WITH ELGO-DIMITRA Source text for Eikon: Further company coverage:
March 22 (Reuters) - Evgen Pharma PLC: * EVGEN PHARMA PLC - PRELIMINARY RESULTS FROM PHASE 1B STUDY * EVGEN PHARMA PLC - PRELIMINARY PHARMACOKINETIC RESULTS FROM PHASE 1B STUDY OF NEW SFX-01 TABLET
March 22 (Reuters) - Sareum Holdings PLC: * SAREUM HOLDINGS PLC - CASH AT 31 DECEMBER 2022 OF £2.9M (£5.6M AS OF 31 DECEMBER 2021 AND £4.3M AS OF 30 JUNE 2022) Source text for Eikon: Further company
March 22 (Reuters) - Arecor Therapeutics PLC: * ARECOR THERAPEUTICS - FIRST PATIENT DOSED IN AT278 CLINICAL TRIAL * ARECOR THERAPEUTICS PLC - TRIAL EXPECTED TO COMPLETE IN Q4 2023 Source text for